Expanded Recall of Warfarin Level Monitoring Test Strips
Inaccurate results may put patients at risk for serious injury or death
Read More
Month: February 2019
Washington State Measles Cases Now at 48 Since Jan. 1
Thirty-four cases involved children ages 1 to 10; 41 patients not vaccinated against measles
Read MoreDenver to vote on whether to decriminalize ‘magic mushrooms’
By Keith Coffman DENVER (Reuters) – Denver voters will decide in May whether to decriminalize possession of small amounts of the hallucinogenic drug psilocybin, which would make it the first U.S. city to halt prosecution...
Read More
U.S. high court temporarily blocks Louisiana abortion restrictions
By Lawrence Hurley WASHINGTON (Reuters) – The U.S. Supreme Court on Friday temporarily...
Read More
Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva
By Caroline Humer NEW YORK (Reuters) – A top U.S. pharmacy benefit manager (PBM) owned by...
Read MorePilgrim’s Pride latest company to recall chicken products over rubber contamination
(Reuters) – Pilgrim’s Pride Corp is recalling about 60,000 pounds of chicken products due to possible rubber contamination, a U.S. public health watchdog said on Friday, making it the third American meat producer in...
Read MoreFDA declines to approve Alkermes opioid-based depression drug
(Reuters) – The U.S. Food and Drug Administration on Friday declined to approve Alkermes Plc’s opioid-based depression treatment, citing the need for additional data to prove the effectiveness of the drug. The...
Read MoreMother’s friendships may be good for babies’ brains
By Lisa Rapaport (Reuters Health) – When new mothers have friends ready to step in and help them, they have toddlers who score better on cognitive tests than the babies of women with smaller social support networks, a U.S....
Read More
Novartis’s cancer therapy wins UK backing after initial lymphoma snub
ZURICH (Reuters) – Novartis’s Kymriah cell therapy won the blessing of health...
Read MoreUse of Valium and Xanax for pain rising in U.S.
By Lisa Rapaport (Reuters Health) – A growing number of people in the U.S. are taking anti-anxiety drugs like Valium and Xanax not just for anxiety or depression but also for chronic pain, researchers say. These drugs are...
Read More
Teen e-cigarette use linked to eventual smoking
By Linda Carroll (Reuters Health) – Among teens, using e-cigarettes may raise the risk of...
Read More
Doctors describe treatment options for adolescent depression
By Carolyn Crist (Reuters Health) – When a teen is diagnosed with depression, it’s...
Read More
EU to send inspectors to Poland over suspect meat
BRUSSELS/WARSAW (Reuters) – The European Commission said on Friday it will send a team of...
Read More
Teva’s migraine drug gets EU panel nod
(Reuters) – Teva Pharmaceutical Industries said a European Medicines Agency (EMA) panel on...
Read More
A matter of life and death? UK stockpiles drugs as no-deal Brexit feared
By Edward Baran LONDON (Reuters) – With just 56 days until Britain leaves the EU, Jo Elgarf...
Read More
EU to send inspectors to Poland over suspect meat
BRUSSELS/WARSAW (Reuters) – The European Commission said on Friday it will send a team of...
Read More
Missouri Supreme Court suspends second talc cancer trial in weeks
By Tina Bellon (Reuters) – The Missouri Supreme Court on Thursday halted an upcoming trial...
Read More
U.S. court blocks San Francisco health warning on soda ads
By Tina Bellon (Reuters) – A U.S. appeals court on Thursday blocked a San Francisco law...
Read More
January 2019 Briefing – Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. FDA Approves First Generic Version of Advair for […]
Read More
January 2019 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Long-Term Incidence of A-Fib Increased in Women With […]
Read More